ArtVentive Medical Group Inc. (OTC:AVTD) signed an agreement with Northwest Clinical Research Group Inc. to prepare for regulatory processes in the U.S. and abroad.
The deal provides for Woodinvill, Wash.-based NCRG to assist ArtVentive in building its quality systems and securing Food & Drug Administration and European CE Mark approvals.
ArtVentive President Jim Graham said the deal with NCRG is "essential" to achieving his company’s regulatory goals.
The San Marcos, Calif.-based endoluminal occlusion devices developer late last month signed a development and manufacturing agreement with Medical Murray Inc. designed help the company commercialize its products more quickly.